{
  "issues": [
    "Renal function labs required for safe contrast administration are missing (eGFR, serum creatinine, BUN, potassium) and have no timestamps.",
    "No clinical indication or urgency (emergent vs. non‑emergent) for the imaging study was provided.",
    "Agent 2’s suggested protocols (LI‑RADS liver protocol and trauma CT) are selected without knowledge of the patient’s actual indication, making them potentially inappropriate.",
    "Renal tool confidence (0.52) is low, reflecting insufficient data to make a reliable safety assessment."
  ],
  "recommendations": [
    "Obtain up‑to‑date renal function labs (eGFR, serum creatinine, BUN, potassium) with documented timestamps before any contrast‑enhanced CT is ordered.",
    "Clarify the primary clinical question for imaging and whether the study is emergent or can be scheduled electively.",
    "If the study is non‑emergent, defer contrast‑enhanced CT until labs are available; consider non‑contrast CT or MRI (without gadolinium) in the interim.",
    "If the study is emergent and labs are available:",
    "  • Verify eGFR ≥30 mL/min/1.73 m² before using iodinated contrast.",
    "  • For eGFR 30–60 mL/min/1.73 m², use low‑dose or split‑bolus techniques and follow KDIGO hydration protocols.",
    "  • For eGFR <30 mL/min/1.73 m², avoid iodinated contrast; consider MRI without gadolinium or alternative imaging modalities.",
    "Select an imaging protocol only after the indication, urgency, and renal function are known; the LI‑RADS liver protocol is appropriate only for patients with chronic liver disease/HCC, while the trauma protocol is appropriate only for trauma patients.",
    "Document the decision‑making process and include renal safety notes in the imaging order."
  ],
  "confidence": 0.45999999999999996,
  "agent2_confidence": 0.84,
  "timestamp": "2025-09-08T16:57:02.469467Z",
  "tool_outputs": {
    "renal": {
      "tool_id": "renal_tool_v2",
      "checks": [
        {
          "id": "egfr_ckd_epi",
          "units": "ml/min/1.73m2",
          "timestamp": "2025-09-08T16:56:41.926820Z",
          "priority": "critical",
          "value": null,
          "status": "missing",
          "reason": "eGFR not available"
        },
        {
          "id": "creatinine_mg_dl",
          "units": "mg/dL",
          "timestamp": "2025-09-08T16:56:41.926851Z",
          "priority": "critical",
          "value": null,
          "status": "missing",
          "reason": "Creatinine not available"
        },
        {
          "id": "bun_creatinine_ratio",
          "timestamp": "2025-09-08T16:56:41.926868Z",
          "priority": "important",
          "value": null,
          "status": "missing",
          "reason": "Missing BUN or creatinine for ratio."
        },
        {
          "id": "potassium_mmol_l",
          "units": "mEq/L",
          "timestamp": "2025-09-08T16:56:41.926883Z",
          "priority": "important",
          "value": null,
          "status": "missing",
          "reason": "Potassium not available"
        }
      ],
      "summary": {
        "overall": "fail",
        "reasons": [
          "eGFR not available",
          "Creatinine not available",
          "Missing BUN or creatinine for ratio.",
          "Potassium not available",
          "Missing BMI or creatinine.",
          "No lab timestamps provided."
        ],
        "confidence": 0.52
      },
      "metadata": {
        "version": "2.0.0",
        "run_ts": "2025-09-08T16:56:41.926976Z"
      }
    }
  },
  "llm_raw": "{\n  \"issues\": [\n    \"Renal function labs required for safe contrast administration are missing (eGFR, serum creatinine, BUN, potassium) and have no timestamps.\",\n    \"No clinical indication or urgency (emergent vs. non‑emergent) for the imaging study was provided.\",\n    \"Agent 2’s suggested protocols (LI‑RADS liver protocol and trauma CT) are selected without knowledge of the patient’s actual indication, making them potentially inappropriate.\",\n    \"Renal tool confidence (0.52) is low, reflecting insufficient data to make a reliable safety assessment.\"\n  ],\n  \"recommendations\": [\n    \"Obtain up‑to‑date renal function labs (eGFR, serum creatinine, BUN, potassium) with documented timestamps before any contrast‑enhanced CT is ordered.\",\n    \"Clarify the primary clinical question for imaging and whether the study is emergent or can be scheduled electively.\",\n    \"If the study is non‑emergent, defer contrast‑enhanced CT until labs are available; consider non‑contrast CT or MRI (without gadolinium) in the interim.\",\n    \"If the study is emergent and labs are available:\",\n    \"  • Verify eGFR ≥30 mL/min/1.73 m² before using iodinated contrast.\",\n    \"  • For eGFR 30–60 mL/min/1.73 m², use low‑dose or split‑bolus techniques and follow KDIGO hydration protocols.\",\n    \"  • For eGFR <30 mL/min/1.73 m², avoid iodinated contrast; consider MRI without gadolinium or alternative imaging modalities.\",\n    \"Select an imaging protocol only after the indication, urgency, and renal function are known; the LI‑RADS liver protocol is appropriate only for patients with chronic liver disease/HCC, while the trauma protocol is appropriate only for trauma patients.\",\n    \"Document the decision‑making process and include renal safety notes in the imaging order.\"\n  ],\n  \"confidence\": 0.71\n}",
  "hallucination_analysis": {
    "statement_assessments": [
      {
        "text": "Renal function labs required for safe contrast administration are missing (eGFR, serum creatinine, BUN, potassium) and have no timestamps.",
        "type": "issue",
        "classification": "unverified",
        "rationale": "no direct or inferred support found"
      },
      {
        "text": "No clinical indication or urgency (emergent vs. non‑emergent) for the imaging study was provided.",
        "type": "issue",
        "classification": "unverified",
        "rationale": "no direct or inferred support found"
      },
      {
        "text": "Agent 2’s suggested protocols (LI‑RADS liver protocol and trauma CT) are selected without knowledge of the patient’s actual indication, making them potentially inappropriate.",
        "type": "issue",
        "classification": "unverified",
        "rationale": "no direct or inferred support found"
      },
      {
        "text": "Renal tool confidence (0.52) is low, reflecting insufficient data to make a reliable safety assessment.",
        "type": "issue",
        "classification": "unverified",
        "rationale": "no direct or inferred support found"
      },
      {
        "text": "Obtain up‑to‑date renal function labs (eGFR, serum creatinine, BUN, potassium) with documented timestamps before any contrast‑enhanced CT is ordered.",
        "type": "recommendation",
        "classification": "unverified",
        "rationale": "no direct or inferred support found"
      },
      {
        "text": "Clarify the primary clinical question for imaging and whether the study is emergent or can be scheduled electively.",
        "type": "recommendation",
        "classification": "unverified",
        "rationale": "no direct or inferred support found"
      },
      {
        "text": "If the study is non‑emergent, defer contrast‑enhanced CT until labs are available; consider non‑contrast CT or MRI (without gadolinium) in the interim.",
        "type": "recommendation",
        "classification": "unverified",
        "rationale": "no direct or inferred support found"
      },
      {
        "text": "If the study is emergent and labs are available:",
        "type": "recommendation",
        "classification": "unverified",
        "rationale": "no direct or inferred support found"
      },
      {
        "text": "  • Verify eGFR ≥30 mL/min/1.73 m² before using iodinated contrast.",
        "type": "recommendation",
        "classification": "unverified",
        "rationale": "egfr 30.0 not present in KB"
      },
      {
        "text": "  • For eGFR 30–60 mL/min/1.73 m², use low‑dose or split‑bolus techniques and follow KDIGO hydration protocols.",
        "type": "recommendation",
        "classification": "unverified",
        "rationale": "egfr 30.0 not present in KB"
      },
      {
        "text": "  • For eGFR <30 mL/min/1.73 m², avoid iodinated contrast; consider MRI without gadolinium or alternative imaging modalities.",
        "type": "recommendation",
        "classification": "unverified",
        "rationale": "egfr 30.0 not present in KB"
      },
      {
        "text": "Select an imaging protocol only after the indication, urgency, and renal function are known; the LI‑RADS liver protocol is appropriate only for patients with chronic liver disease/HCC, while the trauma protocol is appropriate only for trauma patients.",
        "type": "recommendation",
        "classification": "unverified",
        "rationale": "no direct or inferred support found"
      },
      {
        "text": "Document the decision‑making process and include renal safety notes in the imaging order.",
        "type": "recommendation",
        "classification": "unverified",
        "rationale": "no direct or inferred support found"
      }
    ],
    "counts": {
      "supported": 0,
      "inferred": 0,
      "domain_safe": 0,
      "unverified": 13,
      "contradicted": 0
    },
    "hallucination_score": 0.5,
    "recommendation": {
      "force_revision": true,
      "confidence_reduction": 0.25
    },
    "knowledge_base_summary": {
      "numbers": {},
      "raw_strings_sample": [
        "creatinine not available",
        "egfr_ckd_epi",
        "potassium_mmol_l",
        "creatinine_mg_dl",
        "fhir_based",
        "bun_creatinine_ratio",
        "missing bun or creatinine for ratio.",
        "potassium not available",
        "extracted from fhir",
        "egfr not available"
      ]
    }
  },
  "feedback": {
    "issues": [
      "Renal function labs required for safe contrast administration are missing (eGFR, serum creatinine, BUN, potassium) and have no timestamps.",
      "No clinical indication or urgency (emergent vs. non‑emergent) for the imaging study was provided.",
      "Agent 2’s suggested protocols (LI‑RADS liver protocol and trauma CT) are selected without knowledge of the patient’s actual indication, making them potentially inappropriate.",
      "Renal tool confidence (0.52) is low, reflecting insufficient data to make a reliable safety assessment."
    ],
    "recommendations": [
      "Obtain up‑to‑date renal function labs (eGFR, serum creatinine, BUN, potassium) with documented timestamps before any contrast‑enhanced CT is ordered.",
      "Clarify the primary clinical question for imaging and whether the study is emergent or can be scheduled electively.",
      "If the study is non‑emergent, defer contrast‑enhanced CT until labs are available; consider non‑contrast CT or MRI (without gadolinium) in the interim.",
      "If the study is emergent and labs are available:",
      "  • Verify eGFR ≥30 mL/min/1.73 m² before using iodinated contrast.",
      "  • For eGFR 30–60 mL/min/1.73 m², use low‑dose or split‑bolus techniques and follow KDIGO hydration protocols.",
      "  • For eGFR <30 mL/min/1.73 m², avoid iodinated contrast; consider MRI without gadolinium or alternative imaging modalities.",
      "Select an imaging protocol only after the indication, urgency, and renal function are known; the LI‑RADS liver protocol is appropriate only for patients with chronic liver disease/HCC, while the trauma protocol is appropriate only for trauma patients.",
      "Document the decision‑making process and include renal safety notes in the imaging order."
    ],
    "confidence": 0.45999999999999996
  }
}